Microsphere-based scaffolds for cartilage tissue engineering: Using subcritical CO2 as a sintering agent

Acta Biomaterialia

Volumn 6, Issue 1, 2010, Pages 137-143

  Singh, Milind ^a   Sandhu, Brindar ^b   Scurto, Aaron ^c   Berkland, Cory ^c,d   Detamore, Michael S ^c  

^a Rice University   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c University of Kansas   (United States)

^d UNIVERSITY OF KANSAS   (United States)

Author keywords

Cartilage tissue engineering; Cell loaded implants; Microspheres; Sintering; Subcritical CO2

Indexed keywords

CARTILAGE; CELL ENGINEERING; CELLS; CYTOLOGY; MICROSPHERES; POLYMERIC IMPLANTS; SCAFFOLDS (BIOLOGY); SINTERING;

CARTILAGE TISSUE ENGINEERING; CELL-LOADED IMPLANT; MACROPOROUS; MICRO PARTICLES; POLYMER MICROPARTICLES; POLYMER PROCESSING; SINGLE-STEP; SINTERING AGENTS; SUBCRITICAL CO2; TISSUE ENGINEERING SCAFFOLD;

CARBON DIOXIDE;

CARBON DIOXIDE; MICROSPHERE; POLYGLACTIN; POLYMER; SOLVENT; TISSUE SCAFFOLD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CARTILAGE; CELL VIABILITY; CONTROLLED STUDY; ENVIRONMENTAL TEMPERATURE; FEMALE; FOAMING; MESENCHYME CELL; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SKIN; STROMA CELL; TECHNIQUE; TISSUE ENGINEERING; UMBILICAL CORD;

EID: 70449709022     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2009.07.042     Document Type: Article

References (35)

1. Chun K.W., Yoo H.S., Yoon J.J., and Park T.G. Biodegradable PLGA microcarriers for injectable delivery of chondrocytes: effect of surface modification on cell attachment and function. Biotechnol Prog 20 (2004) 1797-1801
2. Holland T.A., Tabata Y., and Mikos A.G. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Release 101 (2005) 111-125
3. Borden M., Attawia M., Khan Y., El-Amin S.F., and Laurencin C.T. Tissue-engineered bone formation in vivo using a novel sintered polymeric microsphere matrix. J Bone Joint Surg Br 86 (2004) 1200-1208
4. Ruhe P.Q., Hedberg-Dirk E.L., Padron N.T., Spauwen P.H., Jansen J.A., and Mikos A.G. Porous poly(d,l-lactic-co-glycolic acid)/calcium phosphate cement composite for reconstruction of bone defects. Tissue Eng 12 (2006) 789-800
5. Goraltchouk A., Scanga V., Morshead C.M., and Shoichet M.S. Incorporation of protein-eluting microspheres into biodegradable nerve guidance channels for controlled release. J Control Release 110 (2006) 400-407
6. Rosner B.I., Siegel R.A., Grosberg A., and Tranquillo R.T. Rational design of contact guiding, neurotrophic matrices for peripheral nerve regeneration. Ann Biomed Eng 31 (2003) 1383-1401
7. Singh M., Morris C.P., Ellis R.J., Detamore M.S., and Berkland C. Microsphere-based seamless scaffolds containing macroscopic gradients of encapsulated factors for tissue engineering. Tissue Eng C Methods 14 (2008) 299-309
8. Berkland C., Kim K., and Pack D.W. PLG microsphere size controls drug release rate through several competing factors. Pharm Res 20 (2003) 1055-1062
9. Botchwey E.A., Pollack S.R., El-Amin S., Levine E.M., Tuan R.S., and Laurencin C.T. Human osteoblast-like cells in three-dimensional culture with fluid flow. Biorheology 40 (2003) 299-306
10. Botchwey E.A., Pollack S.R., Levine E.M., and Laurencin C.T. Bone tissue engineering in a rotating bioreactor using a microcarrier matrix system. J Biomed Mater Res 55 (2001) 242-253
11. Wu L., and Ding J. In vitro degradation of three-dimensional porous poly(d,l-lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 25 (2004) 5821-5830
12. Tracy M.A., et al. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. Biomaterials 20 (1999) 1057-1062
13. Yao J., Radin S., Leboy P.S., and Ducheyne P. The effect of bioactive glass content on synthesis and bioactivity of composite poly(lactic-co-glycolic acid)/bioactive glass substrate for tissue engineering. Biomaterials 26 (2005) 1935-1943
14. Jaklenec A., Hinckfuss A., Bilgen B., Ciombor D.M., Aaron R., and Mathiowitz E. Sequential release of bioactive IGF-I and TGF-beta(1) from PLGA microsphere-based scaffolds. Biomaterials 29 (2008) 1518-1525
15. Jaklenec A., Wan E., Murray M.E., and Mathiowitz E. Novel scaffolds fabricated from protein-loaded microspheres for tissue engineering. Biomaterials 29 (2008) 185-192
16. Brown J.L., Nair L.S., and Laurencin C.T. Solvent/non-solvent sintering: a novel route to create porous microsphere scaffolds for tissue regeneration. J Biomed Mater Res B Appl Biomater 86B (2008) 396-406
17. Nukavarapu S.P., et al. Polyphosphazene/nano-hydroxyapatite composite microsphere scaffolds for bone tissue engineering. Biomacromolecules 9 (2008) 1818-1825
18. Duarte A.R., Roy C., Vega-Gonzalez A., Duarte C.M., and Subra-Paternault P. Preparation of acetazolamide composite microparticles by supercritical anti-solvent techniques. Int J Pharm 332 (2007) 132-139
19. 2 in the fabrication of polymer systems for drug delivery and tissue engineering. Adv Drug Deliv Rev 60 (2008) 373-387
20. Barry J.J., Silva M.M., Popov V.K., Shakesheff K.M., and Howdle S.M. Supercritical carbon dioxide: putting the fizz into biomaterials. Philos Trans 364 (2006) 249-261
21. Ginty P.J., et al. Mammalian cell survival and processing in supercritical CO(2). Proc Natl Acad Sci USA 103 (2006) 7426-7431
22. Howdle S.M., et al. Supercritical fluid mixing: preparation of thermally sensitive polymer composites containing bioactive materials. Chem Commun 2001 (2001) 109-110
23. Mooney D.J., Baldwin D.F., Suh N.P., Vacanti J.P., and Langer R. Novel approach to fabricate porous sponges of poly(d,l-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials 17 (1996) 1417-1422
24. 2 processing. Biomacromolecules 6 (2005) 2458-2461
25. 2 as solvent: structural characterization. J Biomed Mater Res 62 (2002) 89-98
26. Harris L.D., Kim B.S., and Mooney D.J. Open pore biodegradable matrices formed with gas foaming. J Biomed Mater Res 42 (1998) 396-402
27. Berkland C., Kim K., and Pack D.W. Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions. J Control Release 73 (2001) 59-74
28. Bailey M.M., Wang L., Bode C.J., Mitchell K.E., and Detamore M.S. A comparison of human umbilical cord matrix stem cells and temporomandibular joint condylar chondrocytes for tissue engineering temporomandibular joint condylar cartilage. Tissue Eng 13 (2007) 2003-2010
29. Can A., and Karahuseyinoglu S. Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells 25 (2007) 2886-2895
30. Troyer D.L., and Weiss M.L. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26 (2008) 591-599
31. Wang L., Seshareddy K., Weiss M.L., and Detamore M.S. Effect of initial seeding density on human umbilical cord mesenchymal stromal cells for fibrocartilage tissue engineering. Tissue Eng A 15 (2009) 1009-1017
32. Gibson L.J., and Ashby M.F. Cellular solids: structure and properties (1997), Cambridge University Press, Cambridge
33. Almarza A.J., and Athanasiou K.A. Seeding techniques and scaffolding choice for tissue engineering of the temporomandibular joint disk. Tissue Eng 10 (2004) 1787-1795
34. Nof M., and Shea L.D. Drug-releasing scaffolds fabricated from drug-loaded microspheres. J Biomed Mater Res 59 (2002) 349-356
35. Wang X., and Sanchez I.C. Welding immiscible polymers with a supercritical fluid. Langmuir 23 (2007) 12192-12195